Literature DB >> 8460561

Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas.

W Bonicki1, A Kasperlik-Załuska, W Koszewski, W Zgliczyński, J Wisławski.   

Abstract

Authors analyzed retrospectively the incidence of pituitary apoplexy in a series of 799 pituitary adenomas with respect to the long term follow-up of the patients. Focal vascular abnormalities in histological specimens of tumours, regarded as morphological suggestion of past apoplexy (haemorrhage, ischaemic infarction or necrosis), were established in 113 out of 783 surgical cases (14.4%). Acute clinical onset, justifying the clinical diagnosis of pituitary apoplexy, occurred in 39 patients only (5% of the whole series), 19 of them were subjected to urgent surgical decompression due to severe neurological deficit. The haemorrhagic character of apoplexy was established in most cases requiring immediate surgery. The detailed clinical picture of this condition and its management are discussed with respect to the long term prognosis. On this basis the authors suggest the necessity of surgical treatment in every case of pituitary apoplexy, taking into account not only neurological recovery, but also endocrine and oncological aspects of the disease. The observation that pituitary apoplexy may be a "marker" of tumour invasiveness (even in small, "enclosed" adenomas) is highlighted.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8460561     DOI: 10.1007/bf02112028

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  19 in total

1.  Microadenomas of the human pituitary and their vascularization.

Authors:  W Gorczyca; J Hardy
Journal:  Neurosurgery       Date:  1988-01       Impact factor: 4.654

2.  Pituitary apoplexy in acromegaly.

Authors:  A L Taylor; J L Finster; P Raskin; J B Field; D H Mintz
Journal:  J Clin Endocrinol Metab       Date:  1968-12       Impact factor: 5.958

3.  Pituitary apoplexy: a review and reappraisal.

Authors:  R L Rovit; J M Fein
Journal:  J Neurosurg       Date:  1972-09       Impact factor: 5.115

4.  Pituitary apoplexy after combined test of anterior pituitary function.

Authors:  A J Chapman; G Williams; A D Hockley; D R London
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-06

5.  Pituitary apoplexy associated with a triple bolus test. Case report.

Authors:  M Bernstein; R A Hegele; F Gentili; M Brothers; R Holgate; W C Sturtridge; J Deck
Journal:  J Neurosurg       Date:  1984-09       Impact factor: 5.115

6.  Development of a non-extracted 'two-site' immunoradiometric assay for corticotropin utilizing extreme amino- and carboxy-terminally directed antibodies.

Authors:  S C Hodgkinson; B Allolio; J Landon; P J Lowry
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

7.  Pituitary apoplexy treated by transsphenoidal surgery. A clinicopathological and immunocytochemical study.

Authors:  M J Ebersold; E R Laws; B W Scheithauer; R V Randall
Journal:  J Neurosurg       Date:  1983-03       Impact factor: 5.115

8.  Improvement of pituitary function after surgical decompression for pituitary tumor apoplexy.

Authors:  B M Arafah; J F Harrington; Z T Madhoun; W R Selman
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

9.  Pituitary apoplexy: its incidence and clinical significance.

Authors:  S Wakai; T Fukushima; A Teramoto; K Sano
Journal:  J Neurosurg       Date:  1981-08       Impact factor: 5.115

10.  Nelson's syndrome and spontaneous pituitary tumor infarction.

Authors:  R M Jordan; D M Cook; J W Kendall; C W Kerber
Journal:  Arch Intern Med       Date:  1979-03
View more
  35 in total

1.  Pituitary apoplexy probably due to TRH and GnRH stimulation tests in a patient with acromegaly.

Authors:  H S Dökmetaş; A Selçuklu; R Colak; K Unlühizarci; F Bayram; F Keleştimur
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.

Authors:  Giovanna Aparecida Balarini Lima; Evelyn de Oliveira Machado; Cintia Marques Dos Santos Silva; Paulo Niemeyer Filho; Mônica Roberto Gadelha
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

3.  Pituitary apoplexy in an adrenocorticotropin-producing pituitary macroadenoma.

Authors:  Serap Baydur Sahin; S Cetinkalp; M Erdogan; U Cavdar; G Duygulu; F Saygili; C Yilmaz; A G Ozgen
Journal:  Endocrine       Date:  2010-07-14       Impact factor: 3.633

Review 4.  Pituitary apoplexy.

Authors:  Wenya Linda Bi; Ian F Dunn; Edward R Laws
Journal:  Endocrine       Date:  2014-07-26       Impact factor: 3.633

5.  Visual outcome after transsphenoidal surgery in patients with pituitary apoplexy.

Authors:  Ju-Wan Seuk; Choong-Hyun Kim; Moon-Sul Yang; Jin-Hwan Cheong; Jae-Min Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-06-30

6.  Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report.

Authors:  Tricia Mm Tan; Carmela Caputo; Amrish Mehta; Emma Ci Hatfield; Niamh M Martin; Karim Meeran
Journal:  J Med Case Rep       Date:  2007-08-30

Review 7.  [Hypophyseal coma].

Authors:  B L Herrmann; K Mann
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

8.  Oculomotor nerve palsy in pituitary apoplexy associated with pituitary adenoma: a radiological analysis with fast imaging employing with steady-state acquisition.

Authors:  Yasuo Sasagawa; Hiroyuki Aburano; Kazumasa Ooiso; Masahiro Oishi; Yasuhiko Hayashi; Mitsutoshi Nakada
Journal:  Acta Neurochir (Wien)       Date:  2020-10-31       Impact factor: 2.216

Review 9.  Pituitary apoplexy presenting as Addisonian crisis after coronary artery bypass grafting.

Authors:  Angela Feazel Mattke; John R Vender; Mark R Anstadt
Journal:  Tex Heart Inst J       Date:  2002

10.  Effect of transsphenoidal surgery on decreased visual acuity caused by pituitary apoplexy.

Authors:  Naoya Takeda; Katsuzo Fujita; Shigenori Katayama; Nobuyuki Akutu; Shigeto Hayashi; Eiji Kohmura
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.